Abstract PO-054: A phase II trial of the super-enhancer inhibitor Minnelide in advanced refractory adenosquamous carcinoma of the pancreas (ASCP)

2021 ◽  
Author(s):  
Nebojsa Skorupan ◽  
Mehwish I. Ahmad ◽  
Seth M. Steinberg ◽  
Jane B. Trepel ◽  
Derek Cridebring ◽  
...  
Keyword(s):  
Phase Ii ◽  
Adenosquamous Carcinoma ◽  
Phase Ii Trial ◽  
Carcinoma Of The Pancreas ◽  
Super Enhancer

Phase II trial of gemcitabine-UFT-leucovorin (ILV) in advanced carcinoma of the pancreas: preliminary results

1999 ◽  
Vol 35 ◽  
pp. S156-S157
Author(s):  
J. Feliu ◽  
J.M. Vincent ◽  
J. Dorta ◽  
M. Constenla ◽  
J. Espinosa ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Carcinoma ◽  
Carcinoma Of The Pancreas ◽  
Preliminary Results

1326: Phase II Trial of Gemcitabine, Paclitaxel, and Cisplatin in Advanced Transitional Cell Carcinoma

2005 ◽  
Vol 173 (4S) ◽  
pp. 360-360
Author(s):  
Peter E. Clark ◽  
Diana Stindt ◽  
M. Craig Hall ◽  
Michele Harmon ◽  
James F. Lovato ◽  
...  
Keyword(s):  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Transitional Cell

Axitinib Shrinks Thyroid Cancer in Phase II Trial

2007 ◽  
Vol 40 (14) ◽  
pp. 22
Author(s):  
JANE SALODOF MACNEIL
Keyword(s):  
Thyroid Cancer ◽  
Phase Ii ◽  
Phase Ii Trial

Author response for "A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B‐cell lymphomas"

2020 ◽  
Author(s):  
Barbara Vannata ◽  
Anna Vanazzi ◽  
Mara Negri ◽  
Sarah Jayne Liptrott ◽  
Anna Amalia Bartosek ◽  
...  
Keyword(s):  
B Cell ◽  
Phase Ii ◽  
Marginal Zone ◽  
Phase Ii Trial ◽  
Author Response ◽  
B Cell Lymphomas
Sign in / Sign up

Export Citation Format

Share Document